Cite
HARVARD Citation
Leidner, R. et al. (n.d.). A potential solution to immunosuppression of the tumour microenvironment: results of a phase 1 clinical trial of anti-OX-40 in head and neck squamous cell carcinoma. International journal of oral & maxillofacial surgery. pp. 126-. [Online].